← Leaderboards
Sandeep Dave
Duke University
$11,206,403
Attributed
$11,868,164
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,868,164 · 11
By mechanism
R01$7,898,946 · 4
P01$1,524,708 · 2
R44$1,022,841 · 1
R21$768,982 · 2
P30$352,005 · 1
R43$300,682 · 1
Top collaborators
- Lanie Elizabeth Happ2 shared
Most similar at Duke University
Same institution · by research overlap
- Nenad Bursac$22,509,345
- Jed E Rose$13,228,741
- Henry Yin$16,962,206
- Francis Joseph McClernon$15,864,633
- Loretta G Que$7,960,774
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMutationS LymphomaLymphomaGeneticGenesMalignant NeoplasmsPathway InteractionsGene ExpressionLarge Cell Diffuse Non-Hodgkin&AposIn VivoCellsMolecular ProfilingMolecularTherapeutic TargetGene Expression ProfilingAccountingHeterogeneityGenomicsSubgroupEmployee StrikesExome SequencingKnock-OutKnockout Mice
Grant awards (37)
Validation of Duoseq as a Genomic Swiss Army Knife for the Diagnosis of Lymphomas$1,022,841
R44 · FY2025 · CA
Genetic Origins of Adverse Outcomes in African Americans with Lymphoma$485,691
R01 · FY2025 · CA · contact PI
Clinical and Genetic Origins of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma$416,602
R01 · FY2025 · CA · contact PI
Clinical validation of Duoseq, a Swiss army knife genomic approach to diagnosis of blood cancers$300,682
R43 · FY2025 · CA
Genetic Origins of Adverse Outcomes in African Americans with Lymphoma$461,406
R01 · FY2024 · CA · contact PI
Clinical and Genetic Origins of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma$395,772
R01 · FY2024 · CA · contact PI
Cancer Genetics and Genomics Program$64,417
P30 · FY2024 · CA · contact PI
Genetic Origins of Adverse Outcomes in African Americans with Lymphoma$485,691
R01 · FY2023 · CA · contact PI
Clinical and Genetic Origins of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma$416,602
R01 · FY2023 · CA · contact PI
Targeting histone methylation in PTCL$318,712
P01 · FY2023 · CA · contact PI
Cancer Genetics and Genomics Program$72,653
P30 · FY2023 · CA · contact PI
Targeting histone methylation in PTCL$292,152
P01 · FY2022 · CA · contact PI
Cancer Genetics and Genomics Program$72,653
P30 · FY2022 · CA · contact PI
Targeting histone methylation in PTCL$298,114
P01 · FY2021 · CA · contact PI
Cancer Genetics and Genomics Program$69,948
P30 · FY2021 · CA · contact PI
Targeting histone methylation in PTCL$298,114
P01 · FY2020 · CA · contact PI
Cancer Genetics and Genomics Program$72,334
P30 · FY2020 · CA · contact PI
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma$495,164
R01 · FY2019 · CA · contact PI
Targeting histone methylation in PTCL$317,616
P01 · FY2019 · CA · contact PI
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma$510,478
R01 · FY2018 · CA · contact PI
Understanding the context-dependent roles of mutations in lymphoma.$286,200
R01 · FY2018 · CA · contact PI
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma$510,478
R01 · FY2017 · CA · contact PI
Understanding the context-dependent roles of mutations in lymphoma.$286,200
R01 · FY2017 · CA · contact PI
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma$510,478
R01 · FY2016 · CA · contact PI
Understanding the context-dependent roles of mutations in lymphoma.$286,200
R01 · FY2016 · CA · contact PI
The genetics of hepatosplenic T cell lymphoma$180,599
R21 · FY2016 · CA · contact PI
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma$508,898
R01 · FY2015 · CA · contact PI
Understanding the context-dependent roles of mutations in lymphoma.$286,200
R01 · FY2015 · CA · contact PI
The genetics of hepatosplenic T cell lymphoma$217,108
R21 · FY2015 · CA · contact PI
Understanding the context-dependent roles of mutations in lymphoma.$283,200
R01 · FY2014 · CA · contact PI
Molecular targets in diffuse large B cell lymphoma$236,120
R01 · FY2013 · CA · contact PI
Molecular targets in diffuse large B cell lymphoma$251,191
R01 · FY2012 · CA · contact PI
Exome-wide screening for common mutations in lymphoma$168,521
R21 · FY2012 · CA · contact PI
Molecular targets in diffuse large B cell lymphoma$251,191
R01 · FY2011 · CA · contact PI
Exome-wide screening for common mutations in lymphoma$202,754
R21 · FY2011 · CA · contact PI
Molecular targets in diffuse large B cell lymphoma$258,960
R01 · FY2010 · CA · contact PI
Molecular targets in diffuse large B cell lymphoma$276,224
R01 · FY2009 · CA · contact PI